Back to Journals » OncoTargets and Therapy » Volume 13

Review

Profile of Polatuzumab Vedotin in the Treatment of Patients with Relapsed/Refractory Non-Hodgkin Lymphoma: A Brief Report on the Emerging Clinical Data

       
Total article views   HTML views PDF downloads Totals
13,809 Dovepress* 8,176+ 1,433 9,609
PubMed Central* 5,633 878 6,511
Totals 13,809 2,311 16,120
*Since 8 June 2020
Total mentioned Facebook Delicious Reddit Twitter Others
10 0 0 0 4 6

View citations on PubMed Central and Google Scholar